早期淋巴结阴性食管腺癌复发模式对监测策略的启示
5年累积复发率为12%,肿瘤增大、低分化和病理T2为复发危险因素,Barrett食管为保护因素;复发后中位总生存仅1.04年,症状性复发者生存更短,提示规律监测可能重要。
要点
- 早期淋巴结阴性食管腺癌切除后5年累积复发率为12%。
- 病理T2、肿瘤增大和低分化增加复发风险,Barrett食管为保护因素。
- 复发后中位总生存1.04年,症状性复发者生存显著更短。
核心结论
- 早期淋巴结阴性食管腺癌治愈性切除后5年复发率为12%,复发后生存差,规律监测可能具有重要作用。
主要发现
- 5年累积复发率为12%。
- 复发危险因素包括肿瘤增大、低分化和病理T2疾病(P < .05),病理存在Barrett食管为保护因素。
- T1a、T1b和T2疾病2年内复发率分别为2.5%、6.1%和12%,5年累积复发率分别为8.2%、11.5%和22.2%。
- 复发后中位总生存为1.04年(95%置信区间,0.7-2.4)。
- 无症状复发14例,症状性复发13例,症状性复发者复发后总生存显著更短(0.31年 vs 0.71年,P = .018)。
临床怎么用
- 对早期淋巴结阴性食管腺癌切除术后患者,应考虑规律监测以早期发现复发。
- 病理T2、肿瘤较大或低分化患者复发风险较高,可能需加强监测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There are limited data regarding optimal surveillance after curative resection for esophageal cancer. Once disease recurrence is diagnosed, the prognosis is poor. The purpose of this article was to characterize disease recurrence in patients with early esophageal adenocarcinoma. METHODS: Two hundred sixty patients were identified from a prospective institutional database with pathologic T1 and T2 node-negative disease therapy treated with curative esophagectomy alone for esophageal adenocarcinoma between 1995 and 2017. Competing risk analysis was used to analyze factors associated with recurrence. RESULTS: The 5-year cumulative incidence of recurrence was 12%. Predictive factors for increased risk of recurrence included increasing tumor size, poor differentiation, and pathologic T2 disease (P < .05), whereas presence of Barrett's esophagus on pathology was protective. Recurrence within 2 years was 2.5%, 6.1%, and 12% for T1a, T1b, and T2 disease, respectively. At 5 years cumulative incidence of recurrence was 8.2%, 11.5% and 22.2%, respectively. Median overall survival after recurrence was 1.04 years (95% confidence interval, 0.7-2.4). There were 14 subclinical and 13 symptomatic recurrences; patients with symptomatic recurrence had a significantly shorter overall survival after recurrence occurred (0.31 vs 0.71 years, P = .018). CONCLUSIONS: Among early node-negative patients with esophageal cancer undergoing curative resection, 5-year recurrence was 12%. Survival after recurrence was poor, and only a few patients had isolated locoregional recurrence at time of diagnosis, suggesting that scheduled surveillance may have an important role.
引用
- Nobel TB, Livschitz J, Xing XX, et al. Surveillance Implications of Recurrence Patterns in Early Node-Negative Esophageal Adenocarcinoma. Ann Thorac Surg. 2019. PMID: 31323215. doi:10.1016/j.athoracsur.2019.05.066
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。